ILMN
37
5
DOV
68
7
USB
61
11
MCO
75
2
COF
58
3
SEE
52
6
ADI
47
2
AVY
50
2
TGNA
56
3
MAR
65
2
HRL
41
2
HOG
33
4
NRG
52
3
DVN
18
2
PPL
59
5
QRVO
8
4
DHR
38
3
PWR
72
2
PCAR
56
3
AN
54
4
ILMN
37
5
DOV
68
7
USB
61
11
MCO
75
2
COF
58
3
SEE
52
6
ADI
47
2
AVY
50
2
TGNA
56
3
MAR
65
2
HRL
41
2
HOG
33
4
NRG
52
3
DVN
18
2
PPL
59
5
QRVO
8
4
DHR
38
3
PWR
72
2
PCAR
56
3
AN
54
4
Financhill
Back

AXIM Biotechnologies 10K Form

Sell
5

AXIM
AXIM Biotechnologies

Last Price:
0.0000
Seasonality Move:
30.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXIM News And Ratings

See the #1 stock for the next 7 days that we like better than AXIM

AXIM Financial Statistics

Sales & Book Value

Annual Sales: $39.52K
Cash Flow: $553K
Price / Cash Flow: 0
Annual Sales: $-0.03
Price / Book: 0

Profitability

EPS (TTM): -0.02330
Net Income (TTM): $-4.14M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -103.02%

AXIM Biotechnologies Earnings Forecast

Key AXIM Biotechnologies Financial Ratios

  • The Selling, General & Administrative Expenses for AXIM have been equal to 5,662.55% of Gross Profit Margin.
  • The Research & Development expenses have been 317.56% of Revenue.
  • The Interest Expense is -14.95% of Operating Income.
  • The Net Earning history of AXIM is -20,393.93% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

AXIM Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AXIM
Website: aximbiotech.com

Debt

Debt-to-Equity Ratio: -0.69
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXIM Technical Analysis vs Fundamental Analysis

Sell
5
AXIM Biotechnologies (AXIM) is a Sell

Is AXIM Biotechnologies a Buy or a Sell?